Analyzing Health In Tech (HIT) & Its Rivals

Health In Tech (NASDAQ:HIT) is one of 95 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Health In Tech to similar businesses based on the strength of its valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and profitability.

Valuation & Earnings

This table compares Health In Tech and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health In Tech	$32.83 million	N/A	-14.14
Health In Tech Competitors	$328.62 million	-$23.71 million	12.82

Health In Tech’s competitors have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Health In Tech has a beta of 2.73, indicating that its share price is 173% more volatile than the S&P 500. Comparatively, Health In Tech’s competitors have a beta of 1.15, indicating that their average share price is 15% more volatile than the S&P 500.

Insider and Institutional Ownership

41.7% of shares of all “Healthcare Technology” companies are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 15.9% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Health In Tech and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Health In Tech Competitors	-768.38%	-39.51%	-18.04%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Health In Tech and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Health In Tech Competitors	435	1497	2729	87	2.52

Health In Tech currently has a consensus price target of $3.50, indicating a potential upside of 253.54%. As a group, “Healthcare Technology” companies have a potential upside of 46.74%. Given Health In Tech’s stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than its competitors.

Summary

Health In Tech beats its competitors on 8 of the 12 factors compared.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.